Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases

BMC Cancer

Table 7 Overall survival and local control rates after SFRS/fSBRT or pulmonary metastasectomy according to various studies

Reference	Study design	Year	No. Patients	Primary tumor	No. of LM	Treatment	Overall survival		Local control
Reference	Study design	Year	No. Patients	Primary tumor	No. of LM	Treatment	1-year (%)	2-years (%)	1-year (%)	2-years (%)
Nuyttens et al. [8]	Phase 2 study	2015	30	Various	1 - 5	SFRS/fSBRT	-	63	79	-
Rieber J et al. [9]	Retrospective	2016	700	Various	42% single	SFRS/fSBRT	75.1	54.4	-	81.2
Navarria et al. [10]	Retrospective	2014	76	Various	1 - 5	fSBRT	84.1	73	95	89
Sharma A. et al. [11, 12]	Retrospective	2018	206	Various	1 - 5	SFRS/fSBRT	-	63	-	85
Widder J et al. [13]	Retrospective	2013	110	Various	3 - 5	fSBRT 42, PME 68	SBRT: 87 PME: 98	SBRT: 86 PME: 74	SBRT: 94 PME: 93	SBRT:94 PME:90
Sapir et al. [14]	Retrospective	2016	78	Sarcoma	-	SBRT 26, PME 127	-	SBRT: 57.9, PME: 62.2	-	SBRT: 97.4 PME: 96.8
Filippi et al. [15]	Retrospective	2014	67	Various	1 - 5	SFRS	85.1	70.5	93	88.1
Agolli L [16]	Retrospective	2017	44	CRC	1 - 4 (61% single)	SFRS/fSBRT	-	67.7	68.8	60.2
Present study	Retrospective	2019	52	Various	Median 2	SFRS/fSBRT	84	71	SFRS 89, fSBRT 83	SFRS 83, fSBRT 59

LM lung metastases, SBRT stereotactic body radiotherapy, SFRS single fraction radiosurgery, fSBRT fractionated stereotactic radiotherapy

ISSN: 1471-2407